Cargando…

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity

Biological drugs, such as proteins and immunogens, are increasingly used to treat various diseases, including tumors and autoimmune diseases, and biological molecules have almost completely replaced synthetic drugs in rheumatology. Although biological treatments such as anti-tumor necrosis factor (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benucci, Maurizio, Grossi, Valentina, Manfredi, Mariangela, Damiani, Arianna, Infantino, Maria, Moscato, Paolo, Cinquanta, Luigi, Gremese, Elisa, Tolusso, Barbara, Petricca, Luca, Fedele, Anna Laura, Alivernini, Stefano, Atzeni, Fabiola, Minisola, Giovanni, Verna, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822010/ https://www.ncbi.nlm.nih.gov/pubmed/31650726 http://dx.doi.org/10.3343/alm.2020.40.2.101

Ejemplares similares

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
por: Benucci, Maurizio, et al.
Publicado: (2019)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci, Maurizio, et al.
Publicado: (2016)

Old and new antirheumatic drugs for the treatment of COVID-19
por: Benucci, Maurizio, et al.
Publicado: (2020)

Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19()
por: Benucci, Maurizio, et al.
Publicado: (2020)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2018)

Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2022)

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
por: Benucci, Maurizio, et al.
Publicado: (2020)

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease
por: Benucci, Maurizio, et al.
Publicado: (2022)

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci, Maurizio, et al.
Publicado: (2018)

Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174
por: Benucci, Maurizio, et al.
Publicado: (2023)

Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Elisa, Gremese, et al.
Publicado: (2022)

Correction: Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Gremese, Elisa, et al.
Publicado: (2022)

Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission
por: Alivernini, Stefano, et al.
Publicado: (2016)

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
por: Benucci, Maurizio, et al.
Publicado: (2020)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis
por: Tolusso, Barbara, et al.
Publicado: (2018)

Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
por: Alivernini, Stefano, et al.
Publicado: (2017)

Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study
por: Bruno, Dario, et al.
Publicado: (2021)

Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis
por: Ferraccioli, Gianfranco, et al.
Publicado: (2012)

Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019)

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019)

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015)

Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
por: Alivernini, Stefano, et al.
Publicado: (2018)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)

Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis
por: Di Sante, Gabriele, et al.
Publicado: (2015)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
por: Alivernini, Stefano, et al.
Publicado: (2020)

JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy
por: Gremese, Elisa, et al.
Publicado: (2019)

The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis
por: Biscetti, Federico, et al.
Publicado: (2017)

The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives
por: Gremese, Elisa, et al.
Publicado: (2023)

Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?
por: Benucci, Maurizio, et al.
Publicado: (2022)

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis
por: Alivernini, Stefano, et al.
Publicado: (2018)

MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2016)

Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
por: Ferraccioli, Gianfranco, et al.
Publicado: (2016)

Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs
por: Gremese, Elisa, et al.
Publicado: (2018)

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells
por: Alivernini, S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_egcc1lc6ifrhrfb4tsi8cc0idj